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Experimental and theoretical studies on the factors that control the coordination chemistry of N-donor ligands in square-planar 
complexes of type RhCl(NHC)L1L2 (NHC = N-heterocyclic carbene) are presented. The dinuclear complexes [Rh(µ-Cl)(IPr)(η2-olefin)]2 
{IPr = 1,3-bis-(2,6-diisopropylphenyl)imidazol-2-carbene}, have been reacted with different combinations of ligands including pyridine, 10 
acetonitrile, 2-pyridylacetonitrile, triphenylphosphine, tricyclohexylphosphine, carbon monoxide or molecular oxygen. In addition, the 
reactivity of RhCl(IPr)(PPh3)2 has also been studied. Pyridine preferentially coordinates trans to the carbene ligand whereas π-acceptor 
ligands (olefin, CO or PPh3) are prone to bind cis to IPr and trans to chlorido, unless steric bulk hinders the coordination of the ligand 
(PCy3). In contrast, acetonitrile is more labile than pyridine but it is able to form complexes coordinated cis-to IPr. Molecular dioxygen 
also displaces the labile cyclooctene ligand in RhCl(IPr)(η2-coe)(py) to give a square planar dioxygen adduct which can be transformed 15 
into a peroxo derivative by additional coordination of pyridine. Charge Decomposition Analysis (CDA) shows that σ-donation values are 
similar for coordination at cis- or trans-IPr positions, whereas efficient π-backbonding is significantly observed at cis position being the 
favoured coordination site for π-acceptor ligands. The Rh-IPr rotational barrier in a series of square-planar complexes has been analysed. 
It has been found that main contribution is the steric hindrance of the ancillary ligand. The presence of a π-donor ligand such as chlorido 
slows down the dynamic process. 20 
 
Introduction 
Catalytic efficiency for a specific transition-metal mediated 
transformation requires the appropriate choice of a particular set 
of ligands that determine the catalytic outcome.1 Therefore, a 25 
detailed study of coordination chemistry within intermediate 
species is essential in order to a rational design of active and 
selective catalysts.2 Commonly, organometallic catalysts bear a 
primary ligand, such as cyclopentadienyl, phosphine, alkylidene, 
porphyrin, salen, etc, that accounts for the main catalytic 30 
properties, whereas ancillary ligands or additives frequently tune 
the activity or selectivity in a subtle way. This principal ligand 
may, in certain cases, modulate the position and tightness of 
ancillary ligands and substrates, thus exerting critical influence 
over the catalytic results. N-heterocyclic carbenes (NHCs)3 35 
belong to this class of ligands due to their particular donor-
acceptor properties4 and high steric hindrance5 (Chart 1). 
 
Chart 1. Steric and electronic influence of NHC ligands. 
 An outstanding example of this NHC ligand-management effect 40 
has been recently discovered in our laboratories.6 Addition of 
pyridine to the alkyne hydrothiolation7 catalysts [Rh(µ-
Cl)(NHC)(η2-olefin)]2, dramatically switches the regioselectivity 
to the formation of branched vinyl sulfides. It has been 
demonstrated that pyridine coordination trans to the NHC ligand 45 
in the key hydride-thiolate catalytic intermediate species, directs 
the coordination of the alkyne cis to the carbene ligand. The 
higher trans-influence of the hydride ligand paves the way to a 
cis thiolate-alkyne disposition, thereby favouring thiolate 
insertion. It has been found that subtle modifications on the 50 
pyridine motif significantly accounts for the selectivity, similar to 
other pyridine-modulated catalytic transformations.8 In contrast, 
the addition of other typical N-donor additives such as 
acetonitrile do not affect the selectivity as much as pyridine 
does,9 more likely due to the different coordination capability. 55 
Particularly for M-NHC complexes, a clear trend in favour of one 
of such nitrogenated ligands is not observed and competitive 
coordination of acetonitrile10 or pyridine11 depends on a complex 
interplay between electronic and steric factors. Prompted by these 
precedents, we present herein an experimental and theoretical 60 
study of the coordination of different N-donor ligands into Rh-
NHC square-planar complexes. 
Results and Discussion 
Synthesis of pyridine and acetonitrile complexes 
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 Dinuclear olefin complexes [Rh(µ-Cl)(IPr)(η2-olefin)]2 {olefin 
= coe (cyclooctene) (1), ethylene (2)} {IPr = 1,3-bis-(2,6-
diisopropylphenyl)imidazol-2-carbene} are adequate precursors 
for the preparation of a wide array of mononuclear complexes 
bearing varied ligands.12 As shown previously in our group, 5 
pyridine (py) ligands are able to cleave the chlorido-bridges of 1 
and 2 to generate mononuclear complexes of type RhCl(IPr)(η2-
olefin)(py) {coe (3a), ethylene (3b)}, although the η2-olefin was 
not exchanged even on heating 1 in neat pyridine at 80 ºC for one 
night.6 Now, we have observed that acetonitrile behaves 10 
differently. Unexpectedly, the starting materials were recovered 
unreacted after stirring at room temperature for 3 h a solution of 1 
or 2 in a mixture toluene (2 mL) / acetonitrile (2 mL). However, 
in-situ treatment of toluene-d8 samples of 1 and 2 on an NMR 
tube scale with an excess of acetonitrile (100 µL) showed the 15 
presence of two different species depending on the coordinated 
olefin. In the case of ethylene, the new resonances were ascribed 
to RhCl(IPr)(η2-CH2=CH2)(CH3CN) (4), resulting from 
acetonitrile cleavage of the chlorido-bridges of 2. Complex 4 
likely reverts to the dinuclear species 2 during the isolation 20 
process (Scheme 1).13 The 1H NMR spectrum of 4 at -20 ºC 
showed two doublets at δ 2.47 and 2.33 ppm (JH-H = 12.3 Hz) for 
the η2-olefinic protons and a singlet at 2.15 ppm corresponding to 
the coordinated acetonitrile molecule. The spectrum at room 
temperature showed a broadening of ethylene and IPr signals 25 
indicating a rotational process for both ligands, but unfortunately 
the activation parameters could not be determined.12h The more 
noticeable signals in the 13C{1H}-APT NMR spectrum are two 
doublets at δ 181.4 ppm (JC-Rh = 56.7 Hz) and 41.8 ppm (JC-Rh = 
15.4 Hz) corresponding to the IPr and ethylene ligands. In 30 
contrast, addition of acetonitrile to the η2-coe derivative 1 at room 
temperature gave rise to a new set of signals that grew up after 
heating at 80º C for 5 h with concomitant appearance of free coe. 
The new complex was isolated and characterized as the cationic 
derivative [Rh(IPr)(CH3CN)3]Cl (5), in which not only coe but 35 
chlorido ligands have been replaced by acetonitrile (Scheme 1). 
The structure of 5 was unequivocally unravelled by comparison 
of the 1H and 13C{1H} NMR spectra with those of the triflate salt, 
[Rh(IPr)(CH3CN)3]OTf, that has been recently prepared by 
protonation of Rh(acac)(IPr)(coe) (acac = acetylacetonate) with 40 
triflic acid.12h Interestingly, compound 5 was not obtained on 
heating a solution of an equilibrium mixture of 2 and 4 in CD3CN 
at 80 ºC for 5 h, which demonstrates the different bond strength 
of ethylene and coe.14 Prolonged reaction times led to 
decomposition of the sample. 45 
 
Scheme 1. Bridge-cleavage reactions promoted by N-donor 
ligands. 
 DFT calculations on the thermodynamic equilibrium for the 
exchange reaction between olefin and N-donor ligands in 3 and 4 50 
were performed (Scheme 2). In accordance with the experimental 
results, we have found that the formation of putative disubstituted 
N-donor ligand complexes RhCl(IPr)(py)2 (6t) and 
RhCl(IPr)(CH3CN)2 (7t) is disfavoured by an average of 16.4 
(coe) and 13.0 (ethylene) kcal mol-1. Certainly, the higher π-55 
acceptor capacity of the olefin with regard to pyridine or 
acetonitrile may be determinant in the stability of these electron-
rich RhI derivatives. 
 
Scheme 2. DFT calculated ΔE (kcal mol-1) for the 60 
thermodynamic equilibrium between coordinated olefin and 
pyridine or acetonitrile. 
 In order to further compare the pyridine and acetonitrile 
coordination capabilities, complexes 1 and 2 were treated with 2-
pyridylacetonitrile. At room temperature, the chloride-bridges 65 
were cleaved to give rise to the mononuclear complexes 
RhCl(IPr)(η2-olefin){κ-N,(NC5H4)-2-CH2CN} {coe = (8); 
ethylene (9)}, bearing the pyridine moiety coordinated to the 
metal center and a free nitrile group (Scheme 3). No chelate or 
dinuclear species were observed. Coordination of a second 70 
equivalent of 2-pyridylacetonitrile was observed on heating 8 at 
80 ºC for 3 h. A new orange complex RhCl(IPr){κ-N,(NC5H4)-2-
 3 
CH2CN}{κ-N,NCCH2-2-(C5H4N)} (10) was isolated in 72 % 
yield, resulting from the replacement of coe by a 2-
pyridylacetonitrile ligand which is coordinated through the 
nitrogen atom of the nitrile group. No other products were 
apparent on the NMR spectra. 5 
 
Scheme 3. Preparation of 2-pyridylacetonitrile rhodium 
complexes. 
 Complex 8 was characterized by X-ray diffraction analysis. 
The molecular structure is displayed in figure 1. The mode of 10 
coordination of the N-donor ligand was corroborated in the solid 
state. The metallic center presents a distorted square-planar 
geometry with the nitrogenated ligand located trans to the IPr 
{C(1)-Rh-N(3) = 167.35(7)°}. The rhodium-carbon separation 
[Rh−C(1) = 1.9835(18) Å] compares well with previously 15 
reported Rh-NHC bond distances.3c,12 Either the wingtips of the 
IPr, coe or pyridylacetonitrile ligands adopt an out-of-plane 
disposition from the square-planar metal environment.  
 
Figure 1. Molecular diagram for 8. Selected bond lengths (Å) 20 
and angles (º): Rh-C(1) = 1.9835(18), Rh-N(3) = 2.1329(16); Rh-
C(35) = 2.1383(19), Rh-C(36) = 2.1066(19), C(35)-C(36) = 
1.402(3); C(1)-Rh-N(3) = 167.35(7), C(1)-Rh-C(35) = 95.19(7), 
C(1)-Rh-C(36) = 94.47(8), C(1)-Rh-Cl = 88.27(5). 
 The 1H and 13C{1H} NMR spectra of 8 and 9 are consistent 25 
with the structure shown in figure 1. The presence of a substituent 
in the 2-position of the pyridine ligand hinders rotation of both 
IPr15 and 2-pyridylacetonitrile ligands resulting in an asymmetric 
molecule. Thus, four and eight signals were observed respectively 
for the CH and CH3 isopropyl-IPr substituents. The four 30 
inequivalent protons of coordinated ethylene in 9 appeared as 
doublet of doublets at 2.63, 2.22, 1.91, and 1.37 ppm with 
homonuclear couplings of 11.3 and 8.2 Hz. Notably, the 
diastereotopic methylene protons of the dangling nitrile group 
were observed as doublets at δ 5.79 and 3.76 ppm, (JH-H = 20.0 35 
Hz) for 8 or 4.97 and 3.98 ppm (JH-H = 20.1 Hz) for 9. In the 
13C{1H}-APT NMR spectra, the resonances assigned to carbon 
atoms directly bonded to rhodium appeared as doublets around 
183 ppm (JC-Rh = 54 Hz) for IPr, 60.0 (JC-Rh = 16.6 Hz) and 52.8 
ppm (JC-Rh = 14.1 Hz) for coe and 44.8 (JC-Rh = 17.6 Hz) and 37.4 40 
ppm (JC-Rh = 15.8 Hz) for ethylene. The 1H-15N HMBC spectrum 
of 8 confirmed the coordination of the pyridine motif, δ 270.5 vs 
315.2 ppm for the free 2-pyridylacetonitrile.12i 
 The proposed structure for complex 10 was supported by NMR 
spectra. The 1H spectrum displayed two sets of signals for both 45 
methylene groups of either N-donor ligand, one broad signal at 
3.32 ppm integrating for two protons and two doublets at 2.75 
and 2.67 ppm each integrating for one proton. Similarly to 8 and 
9, the two doublet resonances were ascribed to a κ-N,pyridine 
coordinated trans to IPr, whereas the broad resonance 50 
corresponds to a 2-pyridylacetonitrile ligand coordinated through 
the nitrile moiety in cis position to IPr.16 In fact, a dynamic 
behaviour with the nitrogenated molecule in solution can be 
inferred from the 1H-15N HMBC spectrum. The signal 
corresponding to nitrogen atom of the pyridine appears at δ 315.6 55 
ppm, close to the free ligand value, whereas the nitrile-nitrogen 
atom resonates at 241.9 ppm, with a deviation of 12 ppm high 
field shifted indicating coordination to metal centre. In addition, 
the 13C{1H}-APT NMR spectrum displays just one deshielded 
doublet at 168.9 ppm with JC-Rh = 50.5 Hz, corresponding to the 60 
IPr ligand and two set of carbon atoms for each 
pyridylacetonitrile ligands. Moreover, an NMR sample of 10 in 
CD3CN showed the disappearance of the signals corresponding to 
the κ-N,cyano ligand and not those of the κ-N,pyridine group, 
while resonances corresponding to free 2-pyridylacetonitrile 65 
emerged due to an exchange process with the deuterated solvent. 
 Preparation of phosphine complexes 
 The observed coordination preference of N-donor ligands to 
bulky NHC-rhodium-chlorido square-planar complexes may arise 
from electronic or steric factors. Thus, comparison with other 70 
ubiquitous ligands in organometallic catalysis as 
triphenylphosphine was undertaken. Treatment of 
RhCl(IPr)(PPh3)2 (11) with pyridine at room temperature for 20 
min led to the formation of RhCl(IPr)(PPh3)(py) (12), by 
phosphine-pyridine exchange,17 which was isolated as a yellow 75 
solid in 83 % yield (Scheme 4). In a similar way to the observed 
for the dinuclear complexes 1-2, only the phosphine trans to IPr 
was replaced by pyridine, even when neat pyridine was used as 
solvent.  
 80 
Scheme 4. Pyridine-phosphine exchange reaction leading to 
RhCl(IPr)(PPh3)(py) (12). 
 Single crystals of 12 were obtained by slow diffusion of n-
hexane over a saturated toluene solution of the compound. A 
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view of the molecular structure is depicted in Figure 2. Similarly 
to 8, the metal in 12 presents a distorted square-planar geometry 
with the pyridine located trans to the IPr {C(1)-Rh-N(3) = 
172.19(7)°} and a rhodium-carbon separation of 1.9761(19) Å. A 
significative π−π stacking between the pyridine ligand and a 5 
phenyl group was evident from the structural data (centroid-
centroid distance 3.656 Å; dihedral angle between planes 20.2º) 
with potential implications both on structure stability and on 
fluxional (rotational) behaviour. 
 10 
Figure 2. Molecular diagram for 12. Selected bond lengths (Å) 
and angles (º): Rh-C(1) = 1.9761(19), Rh-N(3) = 2.1089(17), Rh-
P = 2.2124(6); C(1)-Rh-N(3) = 172.19(7), C(1)-Rh-P = 98.22(6), 
N(3)-Rh-P = 89.29(5), Cl-Rh-P = 172.24(2). 
 The NMR data for 12 in C6D6 are in agreement with the 15 
structure observed in the solid state. The 31P{1H} NMR spectrum 
displays a doublet at δ 45.3 ppm with a JP-Rh = 222.0 Hz, typical 
for a trans chlorido-phosphine complex,12a whereas the IPr 
carbon atom shows in the 13C{1H} NMR spectrum a small C-P 
coupling of 15.6 Hz in accordance with a cis carbene-phosphine 20 
disposition.  
 The coordination of the bulky triphenylphosphine ligand cis to 
the hindered IPr in 12 is rather surprising. The high trans-effect of 
the IPr ligand should promote the exchange of the trans 
phosphine in 11, thus favouring kinetically the isomer observed 25 
for 12. However, this configuration is also thermodynamically 
favoured as no isomerization was observed on heating a sample 
of 12 at 60 ºC for 2 h. DFT calculations on the ground state are in 
accordance with experimental results (Figure 3). Isomer 12at 
with the pyridine located trans to IPr18 is 5.4 and 5.8 kcal mol-1 30 
more stable than those with PPh3 (12bt) and chlorido19 (12ct) in 
that position. In this case, in contrast to that observed for 2-
pyridylacetonitrile coordination in 10, both phosphine and 
pyridine suffer from steric hindrance when located cis to the 
bulky IPr, thus, a rational explanation for the preference of PPh3 35 
to coordinate cis to IPr should be its slightly higher π-acceptor 
capacity with regard to pyridine.20 
 
Figure 3. DFT-computed energies for the possible stereoisomers 
of 12 (ΔE, kcal mol-1). 40 
 Acetonitrile behaves in a different way than pyridine does. 
Treatment of 11 with acetonitrile at room temperature resulted in 
the isolation of the starting material, similarly to that observed for 
1 and 2. However, a sample of 11 dissolved in CD3CN led to the 
in-situ formation of two isomers of the complex 45 
RhCl(IPr)(PPh3)(CD3CN) (13) in a 70:30 ratio (Scheme 5).21 The 
31P{1H} NMR spectrum displays, in addition to a signal 
corresponding to free PPh3, two new doublets at 41.9 and 22.3 
ppm with JP-Rh of 206.7 and 89.4 Hz, respectively. In accordance 
with that observed for phosphine-pyridine complex 12, the 50 
derivative with the highest rhodium-phosphine scalar coupling 
was ascribed to the isomer having a cis IPr-phosphine 
configuration (13a), whereas the minor isomer presented trans 
IPr-phosphine disposition (13b). Complex 13a seems to be 
kinetically favoured over 13b. A CD3CN solution of 12 showed 55 
the exclusive formation of 13a resulting from the 
pyridine/acetonitrile exchange. Heating the sample at 60 ºC for 
48 h gave rise to the formation of a new cationic bis-acetonitrile 
complex [Rh(IPr)(PPh3)(CH3CN)2]Cl (14), with a phosphine-
carbene trans disposition (Figure 4). The same complex was 60 
obtained on heating a mixture of 13a and 13b arising from 11. 
The stabilization gained from a mutually trans disposition of 
acetonitrile ligands in 14 would likely account for the formation 
of only one isomer with phosphine-carbene trans configuration. 
 65 




Figure 4. 31P{1H} NMR spectra of 13 and 14. 
 The triflate (OTf) salt of 14, [Rh(IPr)(PPh3)(CH3CN)2]OTf 
(15), has been independently prepared by treatment of the 
cationic derivative [Rh(IPr)(CH3CN)3]OTf12h with PPh3. The 5 
more noticeable features of the NMR spectra of 15 are the 
doublet at δ 37.1 ppm with a JP-Rh of 120.7 Hz in the 31P{1H} 
NMR spectrum, and the resonance at δ 185.3 ppm (dd, JC-P of 
114.6 Hz, and JC-Rh of 46.5 Hz) in the 13C{1H} for the carbene 
carbon atom indicating a trans IPr-phosphine configuration. DFT 10 
calculations on the ground state of 13 show that, in contrast to 
that observed for pyridine-phosphine isomers of 12, both isomers 
of 13 present very similar computed energies (Figure 5). 
 
Figure 5. DFT-computed energies for possible stereoisomers of 15 
13 (ΔE, kcal mol-1). 
 In contrast to the behaviour observed for complexes containing 
PPh3 ligands, treatment of RhI-NHC dimer 1 with a bulkier and 
more electron-rich phosphine such as tricyclohexylphosphine 
(PCy3) in N-donor solvents led to different results (Scheme 6). 20 
The phosphine did not incorporate into the metallic complex in 
pyridine solutions at 60 ºC for one night and pure Rh-NHC-
pyridine complex 3a was isolated. However, a new NHC-
phosphine complex RhCl(IPr)(PCy3)(CH3CN) (16) was obtained 
from acetonitrile solutions after 30 min at 60 ºC. The 31P{1H} 25 
NMR spectrum in CD3CN of 16 displays a doublet at δ 34.6 ppm 
with JP-Rh of 118.8 Hz, indicating a trans NHC-phosphine 
disposition. Moreover, the carbene carbon atom resonates in the 
in the 13C{1H}-APT NMR spectrum as a doublet of doublets at δ 
188.8 ppm with typical couplings JC-Rh of 44.3 Hz and JC-P of 30 
106.9 Hz, corroborating the proposed configuration. These results 
can be rationalized assuming the high steric encumbrance of 
PCy3 and the affinity of pyridine for trans-to-IPr coordination. 
 
Scheme 6. Reactivity of 1 with PCy3 in different nitrogenated 35 
solvents. 
 Coordination of small molecules 
 In order to broaden the study of the effect of IPr over 
coordination of the ancillary ligands in square-planar RhI 
complexes, the reactivity with small molecules such as CO and 40 
dioxygen was also investigated. Treatment of 1 or 3a with CO in 
pyridine as solvent at room temperature led to the formation of 
RhCl(IPr)(CO)(py) (17) (Scheme 7). In contrast, bubbling carbon 
monoxide through a solution of 1 in acetonitrile led to the 
isolation of the bis-carbonyl complex RhCl(IPr)(CO)2.12b The 45 
coordination of pyridine trans to IPr of 17 was substantiated by 
the high JC-Rh coupling constant (82.0 Hz) displayed for the CO 
carbon atom in the 13C{1H} NMR spectrum, which is typical for a 
mutually trans chlorido-CO disposition.22 1H VT-NMR spectra of 
17 in CD2Cl2, showed a dynamic behaviour as result of carbene 50 
rotation around the Rh-IPr bond (Figure 6).15 The activation 
parameters obtained from the corresponding Eyring analysis were 
ΔH≠ = 10.6 ± 0.3 kcal·mol–1 and ΔS≠ = 0.2 ± 0.6 cal·K–1 mol–1 
which lay in the range of those previously reported for Rh-IPr 
complexes.6,12h,15  55 
 
Scheme 7. Reactivity of 3a with small molecules. 
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Figure 6. Variable temperature NMR spectra of 17 in CD2Cl2 
showing the coalescence of the CH-isopropyl (IPr): experimental 
(left) and calculated (right).  
 Complex 3a reacts very fast with molecular oxygen. Bubbling 5 
air through a toluene solution of 3a for 15 min at room 
temperature resulted in the formation of complex 
RhCl(IPr)(O2)(py) (18), that was isolated as a green solid in 70 % 
yield. Prolonged reaction times under air gave rise to unidentified 
products, as previously described by the Crudden´s group.12f We 10 
were not able to isolate any clean complex from the similar 
treatment of 1 in acetonitrile solutions. Addition of pyridine to 18 
led to the formation of the bis-pyridine adduct RhCl(IPr)(O2)(py)2 
(19) which was isolated as a yellow solid in 75% yield. The 
coordination of dioxygen to transition metal complexes very 15 
often results in the formation of monodentated dioxygen adducts 
{1O2} or peroxo {O22-} complexes.23 In this particular case, 
complex 18 is better described as a tetracoordinated RhI{1O2}24 
species whereas 19 points to a RhIII{O22-}25 hexacoordinated 
compound. Suitable single crystals for X-ray determination were 20 
obtained by slow diffusion of n-hexane into saturated toluene 
solutions of 18 and 19. A diagram of the molecular structures is 
shown in figure 7. 
 
Figure 7. Molecular diagram for 18 and 19. Selected bond 25 
lengths (Å) and angles (º), 18: Rh-C(6) = 1.984(3), Rh-O(1) = 
1.959(5), Rh-N(1) = 2.146(3), O(1)-O(1)´ = 1.424(11), Rh-Cl = 
2.287(2); C(6)-Rh-N(1) = 178.33(12), O(1)-Rh-O´(1) = 42.6(3), 
O(1)-Rh-N(1) = 88.73(17); 19: Rh-C(11) = 2.0081(17), Rh-O(1) 
= 1.9884(12), Rh-O(2) = 1.9819(13), Rh-N(1) = 2.1541(15), Rh-30 
N(2) = 2.1462(15), O(1)-O(2) = 1.4399(17), Rh-Cl = 2.4057(4); 
C(11)-Rh-N(1) = 170.67(6), C(11)-Rh-N(2) = 101.44(6), O(1)-
Rh-O(2) = 42.53(5), O(1)-Rh-N(2) = 109.33(5), Cl-Rh-O(2) = 
118.83(4), N(1)-Rh-N(2) = 87.80(6), C(11)-Rh-Cl = 89.37(5). 
 Complex 18 shows a square-planar structure with a carbene-35 
pyridine trans disposition {C(6)-Rh-N(1) = 178.33(12)°}, typical 
of RhI species, whereas compound 19 is better described as a 
distorted octahedron with one pyridine ligand trans to IPr {C(11)-
Rh-N(1) = 170.67(6)°} and the other nitrogenated ligand cis 
disposed {C(11)-Rh-N(2) = 101.44(6)°} more characteristic of 40 
RhIII complexes. The O−O distance in 19 {1.4399(17)} lies 
within the range described for Rh-peroxo complexes (1.43-1.50 
Å). The dioxygen separation in 18 {1.424(11) Å} is only slightly 
shorter than that in 19, with its accuracy affected by the positional 
disorder of the ligand (see experimental). However, the O-O 45 
stretching mode in the IR spectra was observed at 965 cm-1 for 18 
and 879 cm-1 for 19, which reflects the different character of the 
dioxygen ligand in both complexes. The formation of the 
oxidized complex 19 is likely favoured by the ability of 18 to 
easily accommodate a new ligand, a pyridine in this case, 50 
changing the coordination mode of the dioxygen molecule. 
 The NMR spectra of 18 are in agreement with a IPr-pyridine 
trans coordination in a Cs-symmetric compound. In contrast, the 
NMR of 19 in CD2Cl2 showed no equivalent pyridine ligands and 
also evidenced the presence of a symmetry plane that makes 55 
equivalent two isopropyl groups which points to the ionization of 
the chlorido ligand in solution to give the [Rh(IPr)(O2)(py)2]Cl 
species. Similarly to 17, complexes 18 and 19 showed a dynamic 
behaviour as evidenced in a 1H VT-NMR study due to IPr 
rotation. The activation parameters obtained from the 60 
corresponding Eyring analysis were ΔH≠ = 9.9 ± 0.6 kcal·mol–1 
and ΔS≠ = -4.2 ± 1.7 cal·K–1 mol–1 for 18 and ΔH≠ = 13.0 ± 0.7. 
kcal·mol–1 and ΔS≠ = 2.8 ± 1.5 cal·K–1 mol–1 for 19. The 
rotational barrier for 18 is the lowest ever calculated for similar 
RhI-IPr complexes (Table 1). It is generally assumed that the 65 
steric hindrance of the auxiliary ligands on the Rh-IPr motif play 
a fundamental role in the activation barriers for the rotation.15 For 
example, the phosphine complex RhCl(IPr)(η2-
CH2=CH2)(PPh3)15 show the higher value (entry 2, table 1). In 
addition, η2-coe complexes have slightly higher values than η2-70 
ethylene ones (entries 4 vs 5 and 6 vs 7, table 1). Nevertheless, a 
 7 
bulky environment is not the sole factor that contributes to the 
rotational barrier. It has been proposed that the lone pair of 
electrons of a π-donor ligand such as chlorido may interact with 
the empty p-orbital of the NHC,26 thus affecting the rotation. In 
the present case, the chlorido-IPr complex 3a exhibits a higher 5 
rotational barrier (15.1 ± 0.7 kcal·mol–1, entry 4, table 1) than the 
acac-IPr complex (12.7 ± 0.4 kcal·mol–1, entry 6, table 1) or a 
cationic free-chlorido derivative (12.7 ± 0.3 kcal·mol–1, entry 8, 
table 1). 
Table 1. Comparison of rotational barriers for various RhI-IPr 10 
complexes.a 
Entry Complex ΔH≠ (kcal·mol-1) 
 1 RhCl(=CHPh)(IPr)PPh315h 13.4 ± 0.8 
 2 RhCl(η2-CH2=CH2)(IPr)PPh315h 16.6 ± 0.7 
 3 [Rh(µ-Cl)(IPr)(η2-CH2=CH2)]2 (2)6 11.8 ± 0.4 15 
 4 RhCl(IPr)(py)(η2-coe) (3a)6 15.1 ± 0.7 
 5   RhCl(IPr)(py)(η2-ethylene) (3b)6 14.1 ± 0.6 
 6 Rh(acac)(IPr)(η2-coe)12h 12.7 ± 0.4 
 7 Rh(acac)(IPr)(η2-ethylene)12h 10.4 ± 0.3 
 8 [Rh(IPr)(η2-coe)(NCCH3)2]OTf12h 12.7 ± 0.3 20 
 9 RhCl(IPr)(CO)(py) (17) 10.6 ± 0.3 
 10 RhCl(IPr)(O2)(py) (18) 9.9 ± 0.6 
 11 RhCl(IPr)(O2)(py)2 (19) 13.0 ± 0.7 
a acac = acetylacetonate, OTf = CF3SO3 
 Charge Decomposition Analysis (CDA) on square-planar 25 
Rh-IPr-Chlorido complexes 
 The relative stability observed in phosphine-pyridine derivative 
12 in favour of a more hindered cis phosphine-IPr configuration 
indicates a notable influence of electronic factors over the whole 
stability of the square-planar complexes. Thus, we have 30 
performed a Charge Decomposition Analysis (CDA)27 between 
the metallic fragment and the π-acceptor ligand in order to better 
explain the observed results. This method provides a deeper 
insight into the nature of the acceptor-donor interactions and it 
has been extensively used to analyse the metal-ligand bonds in 35 
organometallic complexes28 according to the model of Dewar-
Chatt-Duncanson.29 In particular the method allows a 
measurement of the electron donation of the ligand to the metal 
fragment (σ-donation) and the back-donation from the metal 
centre to the ligand moiety (π-backbonding) to be obtained. In 40 
our case the analysis was carried out by measuring the interaction 
of two distinct metal fragments [RhCl(IPr)(py)] ̶ derived from 
12a (fragment A) and 12b (fragment B) with a set of different 
ligands (Scheme 8, Table 2).  
 45 
Scheme 8. CDA study of the bond between metallic fragments A 
and B with different ligands. 
Table 2. CDA calculations for fragments A and B. 
Entry Ligand
 Fragment A Fragment B
 
 L→Rha Rh→L  BEb L→Rh Rh→L  BE 50 
 1 ethylene 0.591 0.347 61.4 0.565 0.246 44.0 
 2 CO 0.518 0.417 67.9 0.553 0.334 50.7 
 3 PPh3 0.396 0.377 65.0 0.322 0.176 49.9 
 4 pyridine 0.235 0.124 40.9 0.251 0.063 31.9 
 5 CH3CN 0.282 0.173 36.2 0.298 0.083 25.6 55 
a Total electrons, sum of contributions from all orbitals. b bond energy in kcal mol-1 
 Table 2 summarises the results obtained with respect to L → 
[Rh] σ-donation, [Rh] → L π-backbonding and the bonding 
energy between fragments A or B and the ligand. In all cases 
bonding energy was higher for fragment A. Nevertheless, σ-60 
donation values are always comparable for fragments A and B, 
thus π-backbonding values should account for the measured 
differences in bonding energies. Such evidence suggests that 
coordination in cis position to the NHC ligand allows for a more 
efficient π-backbonding and consequently, it is the favoured 65 
coordination site for π-acceptor ligands such as CO or PPh3 in 
12a. As expected, pyridine and acetonitrile show both lower π-
acceptor ability but pyridine displays slightly higher bond energy 
than acetonitrile, in agreement with the formation of 8-9.  
 In the analysed case CDA-analysis suggest how the M-L bond 70 
is the result of a complex series of interactions. In the case of 
complex 12a, CDA analysis revealed two prevalent interactions 
(Scheme 9). HOMO -7 represents the L → [Rh] σ-donation and 
contributes to 10.2 kcal mol-1 of the total binding energy of 65.0 
kcal mol-1. It involves a donation of 0.092 electron of 0.396 (23% 75 
of the total σ-donation) from PPh3 to the metallic fragment. The 
second most relevant interaction refers to HOMO -1 which is the 
one providing for a 0.126 electrons of 0.377 (34%) of π-
backbonding from Rh to PPh3, contributing to the total binding 
energy with 8.2 Kcal mol-1.  80 
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Figure 8. Selected molecular orbitals with corresponding 
energies for complex 12a. 
Concluding Remarks 
The electronic and steric factors that control the coordination 5 
chemistry of N-donor ligands in a RhI-NHC-chlorido square-
planar framework have been disclosed. Both experimental and 
theoretical results indicate that pyridine shows a clear tendency to 
coordinate trans to IPr whereas π-acceptor ligands bind 
preferentially cis to IPr and trans to chlorido (olefin, CO or 10 
PPh3), unless steric bulk hinders the coordination of the ligand 
(PCy3). In contrast, acetonitrile binds weaker than pyridine does, 
but it is able to form cis-to IPr complexes. In this system ethylene 
forms stronger coordination bonds than coe. CDA analysis shows 
that σ-donation values are similar for cis- or trans-IPr 15 
coordination, whereas π-backbonding is significantly increased in 
cis position. Molecular dioxygen displaces the labile cyclooctene 
ligand in these square-planar complexes to give a dioxygen 
adduct or a peroxo complex in function of the number of pyridine 
ligands coordinated at the rhodium centre. The influence of 20 
ancillary ligands on the Rh-IPr rotational barrier is mainly steric 
in origin. However, the presence of a π-donor ligand such as 
chlorido, also slows down the dynamic process. The basic 
knowledge on coordination chemistry reported in this work is 
being applied in our group for the design of more efficient 25 
catalysts for C-C and C-X couplings based on the Rh-NHC 
framework. 
Acknowledgement 
Financial support from the spanish Ministerio de Economía y 
Competitividad (MINECO/FEDER) (CTQ2013-42532-P and 30 
CONSOLIDER INGENIO CSD2009-0050 projects), the 
Diputación General de Aragón (DGA/FSE-E07), the ARAID 
Foundation under the program “Jóvenes Investigadores”, and the 
Campus Iberus, are gratefully acknowledged. ADG thanks the 




All reactions were carried out with rigorous exclusion of air using 
Schlenck-tube techniques. Organic solvents were dried by 40 
standard procedures and distilled under argon prior to use or 
obtained oxygen- and water- free from a Solvent Purification 
System (Innovative Technologies). The starting materials 1,12a 2,6 
3a,6 11,12a and 1512h were prepared as previously described in the 
literature. Chemical shifts (expressed in parts per million) are 45 
referenced to residual solvent peaks (1H, 13C) or external H3PO4 
(31P), CFCl3 (19F) or liquid NH3 (15N). Coupling constants, J and 
N, are given in hertz. Spectral assignments were achieved by 
combination of 1H-1H COSY, 13C-APT, and 1H-13C 
HSQC/HMBC experiments. C, H, and N analyses were carried 50 
out in a Perkin-Elmer 2400 CHNS/O analyzer. Infrared spectra 
were recorded on a Perkin-Elmer Spectrum 100 spectrometer, 
using a Universal ATR Sampling Accesory (neat samples). 
Reactivity of 1 or 2 with acetonitrile. A solution of 1 (100 mg, 
0.079 mmol) or 2 (100 mg, 0.091 mmol) in a mixture of toluene 55 
(2 mL) and acetonitrile (2 mL) was stirred at room temperature 
for 3 h. Then, the solution was concentrated to ca. 1 mL and n-
hexane added to induce the precipitation of a orange solid, which 
was washed with n-hexane (3 x 3 mL) and dried in vacuo, 
corresponding to the starting complex. 60 
In-situ formation of RhCl(IPr)(η2-CH2=CH2)(CH3CN) (4). A 
solution of 2 (15 mg, 0.014 mmol) in toluene-d8 (0.5 mL, NMR 
tube) was treated with 100 µL of acetonitrile. 1H NMR (300 
MHz, toluene-d8, 253 K): δ 7.4-6.9 (6H, HPh), 6.66 (s, 2H, 
=CHN), 3.75 and 2.77 (both sept, JH-H = 6.5, 4H, CHMeIPr), 2.47 65 
and 2.33 (both d, JH-H = 12.3, 4H, CH2=CH2), 2.15 (s, 3H, 
CH3CN), 1.65, 1.43, 1.06, and 1.02 (all d, JH-H = 6.5, 24H, 
CHMeIPr). 13C{1H}-APT NMR (75.1 MHz, toluene-d8, 253 K): δ 
181.4 (d, JC-Rh = 56.7, Rh-CIPr), 147.7 and 145.5 (both s, Cq-IPr), 
137.2 (s, CqN), 129.4, 124.3, and 123.7 (all s, CHPh-IPr), 124.3 (s, 70 
=CHN), 118.5 (s, CH3CN), 41.8 (d, JC-Rh = 15.4, CH2=CH2), 28.6 
and 28.5 (both s, CHMeIPr), 25.9, 25.7, 23.4, and 22.9 (all s, 
CHMeIPr), 0.3 (br, CH3CN). 
Preparation of [Rh(IPr)(CH3CN)3]Cl (5). An acetonitrile 
solution (10 mL) of 1 (100 mg, 0.079 mmol) was heated at 80ºC 75 
for 5 h. After removing the solvent in vacuo, addition of n-hexane 
at caused the precipitation of a pale brown solid which was 
washed with n-hexane (3 x 3 mL) and dried in vacuo. 1H NMR 
and 13C{1H} spectra match with that of [Rh(IPr)(CH3CN)3]OTf 
described previously.12h 80 
Preparation of RhCl(IPr)(η2-coe){η1-N(C5H4)-2-CH2CN} (8). 
An orange solution of 1 (300 mg, 0.236 mmol) in toluene (10 
mL) was treated with 2-pyridylacetonitrile (28 µL, 0.25 mmol) 
and it was stirred at room temperature for 1 h. Then, the solvent 
was removed in vacuo and addition of n-hexane caused the 85 
precipitation of a yellow solid which was washed with n-hexane 
(3 x 3 mL) and dried in vacuo. Yield: 278 mg (78%). Anal. 
Calcd. for C42H56N4ClRh: C, 66.79; H, 7.47; N, 7.42. Found: C, 
66.93; H, 7.52; N, 7.48. 1H NMR (500 MHz, toluene-d8, 253 K): 
δ 8.19 (d, JH-H = 5.1, 1H, H6-py), 7.3-7.0 (m, 6H, HPh-IPr), 6.46 (dd, 90 
JH-H = 9.0, 7.7, 1H, H4-py), 6.86 (d, JH-H = 7.7, 1H, H3-py), 6.61 and 
6.51 (both d, JH-H = 1.7, 2H, =CHN), 6.08 (dd, JH-H = 9.0, 5.1, 
1H, H5-py), 5.79 and 3.76 (both d, JH-H = 20.0, 2H, CH2-py), 4.66, 
3.79, 2.72, and 2.02 (all sept, JH-H = 6.5, 4H, CHMeIPr), 3.0 (m, 
2H, =CHcoe), 1.96, 1.53, 1.43, 1.21, 1.18, 1.06, 1.00, and 0.84 (all 95 
d, JH-H = 6.5, 24H, CHMeIPr), 1.6-0.3 (br, 12H, CH2-coe). 13C{1H}-
APT NMR (125.6 MHz, toluene-d8, 253 K): δ 183.3 (d, JC-Rh = 
54.3, Rh-CIPr), 154.5 (s, C2-py), 152.4 (s, C6-py), 149.0, 148.3, 
146.5, and 146.0 (all s, Cq-IPr), 137.2 and 136.8 (both s, CqN), 
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135.8 (s, C4-py), 130.2, 129.8, 124.6, 123.1, 122.9, and 122.6 (all 
s, CHPh-IPr), 124.4 and 123.9 (s, =CHN), 122.8 (s, C3-py), 121.4 (s, 
C5-py), 117.0 (CNpy), 60.0 (d, JC-Rh = 16.6, =CHcoe), 52.8 (d, JC-Rh 
= 14.1, =CHcoe), 30.7, 30.4, 29.3, 29.1, 26.7, and 26.5 (all s, CH2-
coe), 29.7, 29.4, 28.6, and 28.5 (all s, CHMeIPr), 27.7 (s, CH2-py), 5 
27.6, 26.8, 26.3, 26.2, 24.9, 23.1, 23.0, and 21.6 (all s, CHMeIPr). 
15N-1H HMBC (40 MHz, toluene-d8, 298 K): δ 270.5 (Npy), 190.0 
and 189.8 (NIPr). 
Preparation of RhCl(IPr)(η2-CH2=CH2){η1-N(C5H4)-2-
CH2CN} (9). The complex was prepared as described for 8 10 
starting from 2 (300 mg, 0.270 mmol) and 2-pyridylacetonitrile 
(32 µL, 0.29 mmol). Yield: 325 mg (89%). Anal. Calcd. for 
C36H46N4ClRh: C, 64.23; H, 6.89; N, 8.32. Found: C, 64.56; H, 
6.99; N, 8.38. 1H NMR (500 MHz, toluene-d8, 253 K): δ 7.86 (d, 
JH-H = 5.2, 1H, H6-py), 7.3-7.0 (m, 6H, HPh-IPr), 6.38 (dd, JH-H = 15 
9.2, 7.5, 1H, H4-py), 6.75 (d, JH-H = 7.5, 1H, H3-py), 6.59 and 6.44 
(both d, JH-H = 1.5, 2H, =CHN), 5.95 (dd, JH-H = 9.2, 5.2, 1H, H5-
py), 4.97 and 3.98 (both d, JH-H = 20.1, 2H, CH2-py), 4.24, 3.73, 
2.92, and 2.35 (all sept, JH-H = 6.5, 4H, CHMeIPr), 2.63, 2.22, 
1.91, and 1.37 (all dd, JH-H = 11.3, 8.2, 4H, CH2=CH2), 1.88, 20 
1.63, 1.46, 1.30, 1.16, 1.06, 1.05, and 0.93 (all d, JH-H = 6.5, 24H, 
CHMeIPr). 13C{1H}-APT NMR (125.6 MHz, toluene-d8, 253 K): 
δ 182.8 (d, JC-Rh = 54.2, Rh-CIPr), 153.7 (C2-py), 149.7 (s, C6-py), 
149.1, 148.3, 146.4, and 145.7 (all s, Cq-IPr), 137.1 and 137.0 
(both s, CqN), 135.9 (s, C4-py), 129.9, 129.1, 124.9, 124.4, 123.2, 25 
and 122.9 (all s, CHPh-IPr), 124.4 and 123.9 (both s, =CHN), 122.7 
(s, C3-py), 122.5 (s, C5-py), 116.6 (s, CNpy), 44.8 (d, JC-Rh = 17.6, 
CH2=CH2), 37.4 (d, JC-Rh = 15.8, CH2=CH2), 27.0 (s, CH2-py), 
29.7, 29.4, 28.7, and 28.7 (all s, CHMeIPr), 27.3, 26.8, 26.3, 25.9, 
24.5, 23.0, 22.9, and 22.0 (all s, CHMeIPr).  30 
Preparation of RhCl(IPr){(η1-N(C5H4)-2-CH2CN}{(η1-
NCCH2-2-(C5H4)N} (10). A solution of 8 (150 mg, 0.198 mmol) 
in toluene (10 mL) was treated with 2-pyridylacetonitrile (25 µL, 
0.22 mmol) and was heated at 80⁰C for 3 h. Then, the solution 
was concentrated to ca. 1 mL and n-hexane added to induce the 35 
precipitation of a yellow solid, which was washed with n-hexane 
(3 x 3 mL) and dried in vacuo. Yield: 109 mg (72%). 1H NMR 
(500 MHz, C6D6, 298 K): δ 8.34 (d, JH-H = 4.4, 1H, H6-pyb), 7.59 
(br, 1H, H6-pya), 7.3-7.0 (m, 6H, HPh-IPr), 7.31 (br, 1H, H3-pyb), 7.01 
(vt, JH-H = 6.5, 1H, H4-pyb), 6.73 (s, 2H, =CHN), 6.60 (m, 1H, H5-40 
pyb), 6.57 (vt, JH-H = 7.7, 1H, H4-pya), 6.20 (br, 1H, H5-pya), 6.01 (d, 
JH-H = 7.7, 1H, H3-pya), 3.84 and 3.77 (both sept, JH-H = 6.6, 4H, 
CHMeIPr), 3.32 (br, 2H, CH2-pyb), 2.75 and 2.67 (both d, JH-H = 
10.7, 2H, CH2-pya), 1.84 and 1.25 (both d, JH-H = 6.6, 24H, 
CHMeIPr). 13C{1H}-APT NMR (125.6 MHz, C6D6, 298 K):δ 45 
173.0 (s, C2-pya), 168.9 (d, JC-Rh = 50.5, Rh-CIPr), 150.7 (s, C2-pyb), 
149.5 (s, C6-pyb), 147.7 (br, Cq-IPr), 145.2 (s, C6-pya), 136.8 (s, C4-
pyb), 136.7 (s, CqN), 134.1 (s, C4-pya), 130.5 (s, Cp-Ph), 124.3 ( s, 
=CHN), 124.0 and 123.9 (both s, Cm-Ph), 122.4 (s, C5-pyb), 122.2 
(s, C3-pyb), 121.2 (s, C5-pya), 119.7 (s, C3-pya), 117.9 (CNpyb), 116.3 50 
(CNpya), 28.7 and 28.5 (both s, CHMeIPr), 26.5 (s, CH2-pya), 26.4, 
26.3, 23.7 and 23.6 (all s, CHMeIPr), 22.8 (s, CH2-pyb). 15N-1H 
HMBC (40 MHz, toluene-d8, 298 K): δ 315.6 (Npy), 241.9 (NCN), 
193.4 and 192.0 (NIPr). 
 55 
Preparation of RhCl(IPr)(PPh3)(py) (12). A solution of 11 (355 
mg, 0.338 mmol) in pyridine (5 mL) was stirred for 20 min at 
room temperature. Then, the solution was concentrated to ca. 1 
mL and diethyl ether added to induce the precipitation of a 
yellow solid, which was washed with diethyl ether (3 x 3 mL) 60 
and dried in vacuo. Yield: 237 mg (83%). Anal. Calcd. for 
C50H56N3ClPRh: C, 69.16; H, 6.50; N, 4.84. Found: C, 68.92; H, 
6.67; N, 5.07. 1H NMR (300 MHz, C6D6, 298 K): δ 8.28 (d, JH-H 
= 4.2, 2H, H2-py), 7.5-6.7 (23H, HPh, =CHN), 6.41 (t, JH-H = 7.2, 
1H, H4-py), 5.93 (dd, JH-H = 7.2, 4.2, 2H, H3-py), 4.11 and 3.97 65 
(both sept, JH-H = 6.4, 4H, CHMeIPr), 2.04, 1.31, 1.12, and 0.82 
(all d, JH-H = 6.4, 24H, CHMeIPr). 13C{1H}-APT NMR (75.4 
MHz, C6D6, 298 K): δ 190.8 (dd, JC-Rh = 53.0, JC-P = 15.6, Rh-
CIPr), 153.4 (s, C2-py), 149.5 and 144.4 (both s, Cq-IPr), 138.7 (s, 
CqN), 138.1 (d, JC-P = 35.1, CqP), 134.2 (d, JC-P = 12.0, CHo-PPh), 70 
132.7 (s, C4-py), 129.3, 128.5, 127.1, 124.3, and 123.1 (all s, 
CHPh), 124.0 ( s, =CHN), 121.9 (s, C3-py), 29.3 and 28.3 (both s, 
CHMeIPr), 26.7, 26.6, 24.2, and 22.4 (all s, CHMeIPr). 31P{1H} 
NMR (121.5 MHz, C6D6, 298 K): δ 45.3 (d, JP-Rh = 222.0). 
In-situ formation of RhCl(IPr)(PPh3)(CD3CN) (13). Complex 75 
11 (20 mg, 0.019 mmol) was disolved in CD3CN (0.5 mL, NMR 
tube). A mixture 70/30 13a/13b was observed. 31P{1H} NMR 
(161.8 MHz, CD3CN, 298 K): δ 41.9 (d, JP-Rh = 206.7, 13a), 22.3 
(d, JP-Rh = 89.4, 13b). 
Preparation of [Rh(IPr)(PPh3)(CH3CN)2]OTf (15). An 80 
acetonitrile solution (5 mL) of [Rh(IPr)(CH3CN)3]OTf (96 mg, 
0.11 mmol) was treated with PPh3 (29 mg, 0.11 mmol). After 
stirring for 30 min at room temperature, the solution was 
evaporated to dryness. Addition of n-hexane caused the 
precipitation of a white solid which was washed (3 x 3 mL) and 85 
dried in vacuo. Yield: 81mg (74%). Anal.Calcd. for 
C50H57N4SF3O3PRh: C, 60.97; H, 5.83; N, 5.69. S, 3.26. Found: 
C, 60.73; H, 6.29; N, 5.78; S, 3.17. 1H NMR (400 MHz, CD3CN, 
298 K): δ 7.8-6.9 (m, 19H, HPh, =CHN), 2.85 (sept, JH-H = 6.8, 
4H, CHMeIPr), 1.97 (s, 6H, CH3CN), 1.26 and 1.17 (both d, JH-H 90 
= 6.8, 24H, CHMeIPr). 13C{1H}-APT NMR (100.4 MHz, CD3CN, 
298K): δ 185.3 (dd, JC-P = 114.6, JC-Rh = 46.5, Rh-CIPr), 146.1 (s, 
Cq-IPr), 136.4 (s, CqN), 134.0 (d, JC-P = 12.3, CHo-PPh), 132.8 (d, 
JC-P = 37.1, CqP), 129.9, 128.7, 125.3, and 124.7 (both s, CHPh), 
124.0 (s, =CHN), 120.0 (q, JC-F = 320.0, CF3), 117.0 (s, CH3CN), 95 
28.5 (s, CHMeIPr), 25.2 and 21.9 (both s, CHMeIPr), 0.3 (s, 
CH3CN). 31P{1H} NMR (161.8MHz, CD3CN, 298 K): δ 37.1 (d, 
JP-Rh = 120.7). 
Preparation of RhCl(IPr)(PCy3)(CH3CN) (16). An acetonitrile 
solution (5 mL) of 1 (100 mg, 0.079 mmol) was treated with 100 
PCy3 (46 mg, 0.172 mmol). After stirring for 30 min at 60 ºC, the 
solution was evaporated to dryness. Addition of n-hexane caused 
the precipitation of a pale yellow solid which was washed (3 x 3 
mL) and dried in vacuo. Yield: 120 mg (89%). Anal.Calcd. for 
C47H72N3ClPRh: C, 66.53; H, 8.55; N, 4.95. Found: C, 66.37; H, 105 
8.46; N, 5.18. IR (pure solid, cm-1): ν(C≡N) 2255 (W). 1H NMR 
(400 MHz, CD3CN, 298 K): δ 7.56 (t, JH-H = 7.2, 2H, Hp-Ph), 7.43 
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(d, JH-H = 7.2, 4H, Hm-Ph), 7.42 (s, 1H, =CHN), 2.84 (sept, JH-H = 
6.8, 4H, CHMeIPr), 1.99 (s, 3H, CH3CN), 1.9-0.9 (m, 18H, Cy), 
1.32 and 1.14 (both d, JH-H = 6.8, 24H, CHMeIPr). 13C{1H}-APT 
NMR (100.4 MHz, CD3CN, 298K): δ 188.8 (dd, JC-P = 106.9, JC-
Rh = 44.3, Rh-CIPr), 146.8 (s, Cq-IPr), 137.7 (s, CqN), 130.7 and 5 
126.1, (both s, CHPh), 124.6 (s, =CHN), 118.2 (s, CH3CN), 33.0 
(d, JC-P = 17.1, PCH), 30.3 and 27.7 (both s, CH2), 29.4 (s, 
CHMeIPr), 28.5 (d, JC-P = 10.5, PCHCH2), 26.3 and 22.9 (both s, 
CHMeIPr), 1.75 (s, CH3CN). 31P{1H} NMR (161.8MHz, CD3CN, 
298 K): δ 34.6 (d, JP-Rh = 118.8). 10 
Preparation of RhCl(CO)(IPr)(py) (17). A yellow solution of 
3a (100 mg, 0.0785 mmol) in pyridine (10 mL) was bubbled with 
CO, while it was stirred for 15 min at room temperature. Then, 
the solution was concentrated to ca. 1 mL and n-hexane added to 
induce the precipitation of an orange solid, which was washed 15 
with n-hexane (3 x 3 mL) and dried in vacuo. Yield: 84 mg 
(83%). Anal. Calcd. for C33H41N3ClORh: C, 62.51; H, 6.52; N, 
6.63. Found: C, 62.43; H, 6.47; N, 6.77. IR (pure solid, cm-1): 
ν(C=O) 1948. 1H NMR (300 MHz, C6D6, 298 K): δ 8.60 (d, JH-H 
= 4.9, 2H, H2-py), 7.4-7.2 (6H, HPh), 6.85 (s, 2H, =CHN), 6.55 (t, 20 
JH-H = 7.6, 1H, H4-py), 6.14 (dd, JH-H = 7.6, 4.9, 2H, H3-py), 3.58 
(sept, JH-H = 6.7, 4H, CHMeIPr), 1.78 and 1.25 (both d, JH-H = 6.7, 
24H, CHMeIPr). 13C{1H}-APT NMR (75.4 MHz, C6D6, 298 K): δ 
187.0 (d, JC-Rh = 82.0, CO), 182.3 (d, JC-Rh = 52.3, Rh-CIPr), 153.2 
(s, C2-py), 149.8 (s, Cq-IPr), 136.9 (s, CqN), 135.4 (s, C4-py), 129.9 25 
(s, C3-py), 124.2 and 124.0 (both s, CHPh-IPr), 123.2 (s, =CHN), 
28.9 (s, CHMeIPr), 26.3 and 23.1 (both d, CHMeIPr). 
Preparation of RhCl(IPr)(O2)(py) (18). A yellow solution of 3a 
(247 mg, 0.194 mmol) in toluene (10 mL) was bubbled with O2 
or air, while it was stirred for 10 min at room temperature. Then, 30 
the solution was concentrated to ca. 1 mL and n-hexane added to 
induce the precipitation of a green solid, which was washed with 
n-hexane (3 x 3 mL) and dried in vacuo. Yield: 152 mg (70%). 
Anal.Calcd. for C32H41ClN3O2Rh: C, 60.24; H, 6.48; N, 6.59. 
Found: C, 60.12; H, 6.41; N, 6.53. IR (pure solid, cm-1): ν(O-O) 35 
965. 1H NMR (300 MHz, toluene-d8, 263 K): δ 8.58 (d, JH-H = 
5.3, 2H, H2-py), 7.2-7.0 (6H, HPh,), 6.73 (s, 2H,=CHN), 6.61 (t, JH-
H = 6.4, 1H, H4-py), 6.27 (dd, JH-H = 6.4, 5.3, 2H, H3-py), 3.34 
(sept, JH-H = 6.4, 4H, CHMeIPr), 1.61 and 1.17 (both d, JH-H = 6.4, 
24H, CHMeIPr). 13C{1H}-APT NMR (75.4 MHz, toluene-d8, 263 40 
K): δ 167.7 (br, Rh-CIPr), 149.5 (s, C2-py), 146.7 (s, Cq-IPr), 137.1 
(s, CqN), 136.1 (s, C4-py), 129.7 and 123.4 (both s, CHPh-IPr), 122.7 
(s, C3-py), 28.7 (s, CHMeIPr), 26.3 and 23.0 (both s, CHMeIPr). 
Preparation of RhCl(IPr)(O2)(py)2 (19). A green solution of 18 
(100 mg, 0.157 mmol) in toluene (10 mL) was treated with 45 
pyridine (130 µl, 0.160 mmol) and it was stirred at room 
temperature for 15 min. Then, the solvent was evaporated to 
dryness and subsequent addition of n-hexane caused the 
precipitation of a yellow solid which was washed with n-hexane 
(3 x 2 mL) and dried in vacuo. Yield: 88 mg (75%). Anal.Calcd. 50 
for C37H46ClN4O2Rh: C, 61.97; H, 6.47; N, 7.81. Found: C, 
62.20; H, 6.48; N, 7.72. IR (pure solid, cm-1): ν(O-O) 879. 1H 
NMR (400 MHz, CD2Cl2, 298 K): δ 8.59 and 8.23 (both d, JH-H = 
5.4, 4H, H2-py),7.28 (t, JH-H = 7.4, 2H, CHp-Ph-IPr), 7.49 and 7.46 
(both t, JH-H = 7.7, 2H, H4-py), 7.13 (d, JH-H = 7.4, 4H, CHm-Ph-IPr), 55 
7.06 (s, 2H, =CHN), 7.02 and 6.94 (both dd, JH-H = 7.6, 4.9, 4H, 
H3-py), 3.17 (sept, JH-H = 6.7, 4H, CHMeIpr), 1.40 and 1.10 (both 
d, JH-H = 6.7, 24H, CHMeIPr) 13C{1H}-APT NMR (100.6 MHz, 
CD2Cl2, 298 K): δ 162.4 (d, JC-Rh = 52.09, Rh-CIPr), 153.0 and 
149.5 (both s, C2-py), 146.6 (s, Cq-IPr), 137.5 (s, CqN), 136.3 and 60 
135.6 (both s, C4-py), 129.2 and 123.0 (both s, CHPh-IPr), 125.9 (s, 
=CHN), 123.0 and 123.8 (s, C3-py), 28.6 (s, CHMeIPr), 26.0 and 
22.5 (both d, CHMeIPr). 
Crystal Structure Determination. Single crystals for the X-ray 
diffraction studies were grown by slow diffusion of n-hexane into 65 
toluene (8, 18, 19) or benzene (12) solutions of the complexes. X-
ray diffraction data were collected at 100(2) K on a Bruker APEX 
DUO (8, 18, 19) or SMART APEX (12) CCD diffractometers 
with graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å) 
using narrow ω rotations(0.3°). Intensities were integrated and 70 
corrected for absorption effects with SAINT-PLUS,30 and 
SADABS31 programs, both included in APEX2 package. The 
structures were solved by Patterson methods with SHELXS-9732 
and refined, by full matrix least-squares on F2, with SHELXL-
97.33 All the structures were refined first with isotropic and later 75 
with anisotropic displacement parameters for non-disordered non-
H atoms. Specific relevant details on each structure are described 
below. CCDC 1035865-1035868 contain the supplementary 
crystallographic data for this paper. 
Crystal data for 8: C42H56ClN4Rh ·0.5 C6H14; M = 798.39; orange 80 
prism 0.222 × 0.163 × 0.108 mm3; monoclinic, P21/c; a = 
10.1831(4), b = 20.6299(9), c = 19.8046(9) Å, β = 91.3730(10)°; 
Z = 4; V = 4159.3(3) Å3; Dc = 1.275 g·cm-3; µ = 0.510 mm-1; min. 
and max. absorption correction factors 0.834 and 0.939; 2θmax = 
61.10°; 48965 reflections collected, 11930 unique (Rint = 0.0446); 85 
number of data/restraints/parameters 11930/0/704; final GOF 
1.018; R1 = 0.0353 (9367 reflections, I > 2σ(I)); wR(F2) = 0.0875 
for all data. Two atoms in the coe ligand were observed 
disordered; a disorder model with two positions (0.759 and 
0.241(8) occupancies) was established. Half a molecule of hexane 90 
has also been observed in the asymmetric unit. All hydrogen 
atoms have been observed and freely refined, except those of the 
solvent molecule and of the disordered atoms which were 
included in calculated positions and refined with a positional and 
thermal riding model.  95 
Crystal data for 12: C50H56ClN3PRh· 1.5 C6H6; M = 985.47; 
orange prism 0.341 × 0.222 × 0.119 mm3; triclinic, P-1; a = 
11.6031(8), b = 12.7696(9), c = 17.4596(12) Å, α = 79.8850(8), β 
= 78.2321(8), γ = 80.9152(8)°; Z = 2; V = 2473.1(3) Å3; Dc = 
1.323 g·cm-3; µ = 0.474 mm-1; min. and max. absorption 100 
correction factors 0.855 and 0.946; 2θmax = 57.10°; 28870 
reflections collected, 11338 unique (Rint = 0.0231); number of 
data/restraints/parameters 11338/0/594; final GOF 1.076; R1 = 
0.0345 (10165 reflections, I > 2σ(I)); wR(F2) = 0.0806 for all 
data. Two solvent benzene molecules were observed in the crystal 105 
structure, the second located around a center of symmetry. 
Hydrogens were included in calculated positions with riding 
parameters.  
Crystal data for 18: C32H41ClN3O2Rh; M = 638.06; yellow prism 
0.142 × 0.065 × 0.050 mm3; orthorhombic, Pnma; a = 110 
17.4494(10), b = 17.1900(10), c = 10.1596(6) Å; Z = 4; V = 
3047.4(3) Å3; Dc = 1.391 g·cm-3; µ = 0.681 mm-1; min. and max. 
absorption correction factors 0.857 and 0.957; 2θmax = 61.08°; 
34652 reflections collected, 4620 unique (Rint = 0.0652); number 
of data/restraints/parameters 4620/6/296; final GOF 1.024; R1 = 115 
0.0348 (2699 reflections, I > 2σ(I)); wR(F2) = 0.0861 for all data. 
A disorder involving the chloride and the oxygen molecule was 
detected; eventually two positions, at both sides of the metal, 
were considered for each ligand (0.616 and 0.384(6) 
occupancies). All hydrogens were observed in the Fourier maps 120 
and refined as free isotropic atoms. 
 11 
Crystal data for 19: C37H46ClN4O2Rh· 1.5 C7H8; M = 855.34; 
orange prism 0.216 × 0.117 × 0.045 mm3; triclinic; P-1; a = 
10.1915(9), b = 12.3169(10), c = 18.8266(16) Å, α = 
76.3110(10), β = 82.8450(10), γ = 66.7150(10)°; Z = 2; V = 
2107.8(3) Å3; Dc = 1.348 g·cm-3; µ = 0.512 mm-1; min. and max. 5 
absorption correction factors 0.897 and 0.977; 2θmax = 59.28°; 
23523 reflections collected, 10755 unique (Rint = 0.0305); number 
of data/restraints/parameters 10755/0/478; final GOF 1.081; R1 = 
0.0331 (9398 reflections, I > 2σ(I)); wR(F2) = 0.0831 for all data. 
Hydrogens were included in calculated positions and refined with 10 
a common riding model. A clear toluene solvent molecule was 
observed in the crystal structure, its constrained hydrogen atoms 
were also included in the structure. At this stage, six intense 
residuals were observed around a center of symmetry; its planar 
disposition, together with their relative electron density, 15 
suggested and additional highly disordered half molecule of 
toluene (SQUEEZE evaluation: void of 177 Å3, electron density 
of 56 e-). Eventually, the contribution of this disordered molecule 
was extracted from the structure factor list using SQUEEZE 
program.34 20 
Computational details. All calculations were performed with the 
Gaussian09 package35 at the M06 level.36 Rhodium was 
represented by the relativistic effective core potential (RECP) 
from the Stuttgart group and the associated basis set (SDD 
keyword in Gaussian 09).37 The 6-31G(d) basis set was used for 25 
all the other atoms.38 Full optimizations of geometry without any 
constraint were performed, followed by analytical computation of 
the Hessian matrix to confirm the nature of the stationary points 
as minima on the potential energy surface. In the Table XX we 
have reported the computational results including the cartesian 30 
coordinates (in Å), absolute energy (in a.u) and graphical 
representation including selected geometrical parameters. Charge 
decomposition analysis (CDA) have been performed using 
Dapprich and Frenking’s CDA 2.2 program39 using the same 
methods as in the Gaussian calculations. 35 
Determination of rotational barriers. Full line-shape analysis 
of the dynamic 1H NMR spectra of 17, 18 and 19 were carried out 
using the program gNMR (Cherwell Scientific Publishing 
Limited). The transverse relaxation time, T2, was estimated at the 
lowest temperature. Activation parameters ΔH≠ and ΔS≠ were 40 
obtained by linear least-squares fit of the Eyring plot. Errors were 
computed by published methods.40 
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